Searched for
ACTOS
Consumers seek tariff rationalisation on dedicated freight corridorCommenting on the need to rationalise rail tariffs, Manish Puri, president, Association of Container Train Operators (ACTO) said, "Rail is ...- Changes in Banking Regulation Act in worksThe move is aimed at aligning certain sections of the Banking Regulation Act with the norms stipulated by the banking regulator, Reserve Ba...
- Stepathlon Lifestyle announces its CSR initiative ‘Steps for A Cause’'Steps for A Cause’ is a fund raising opportunity will launch at the same time as their 100 Day Race commencing on September 2, 2015.
- Lupin gets USFDA approval for diabetes management drug"Lupin's Pioglitazone tablets is to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings," the co...
- Ranbaxy: Improving US, local businesses to keep stock upRanbaxy’s September quarter performance, which was sans the exclusivity sales of generic Lipitor, was boosted by two authorised generic lau...
- Ranbaxy posts Q3 net profit of Rs 754 croreRanbaxy reported a net profit of Rs 754 crore for the quarter ended September on the back of strong sales in its North American market and ...
- Telecom panel seeks stricter for remote access normsA telecom panel has recommended tightening of norms for remote access, the provision to monitor data traffic on cellular networks.
- Ranbaxy Laboratories launches authorized generic Actos in USRanbaxy has launched authorized pioglitazone hydrochloride tablets, generic version of Takeda's diabetes drug sold under the brand Actos in...
- Windfall likely for Ranbaxy Laboratories after FDA says no to Watson PharmaceuticalsThe US drug regulator's refusal to allow Watson Pharma to launch generic version of diabetes drug could mean windfall for Ranbaxy, accordin...
- Indian drug outlook favourable: ICRA & Moody'sAccording to the report, domestic formulation market size stood at Rs 58,300 crore, ranked third in terms of volume and tenth in terms of v...
- Ranbaxy falls 7% to nine-month low on USFDA settlement costsAnalysts said Ranbaxy could lose millions of dollars in potential revenues and undergo a time consuming process before it resume supplies
- Telcos differ sharply on Trai move to revise interconnect rateTelecom companies have provided sharply differing inputs to TRAI on the move to revise network interconnect charges.
- Indian cos eye $4bn generic opportunityExperts feel that after allowing 90% price erosion once generic drug versions appear in the market, and due to intense competition, the act...
- Glaxo to pull out its diabetes drug from European marketAvandia, manufactured by GlaxoSmithKline, once the world’s best-selling diabetes drug, will be withdrawn from the market in Europe and sale...
- Stocks to watch: Inox Leisure, Ranbaxy, Reliance Communications, Jet Airways, Madhucon ProjectsCement prices could rise again this month-end, the second hike on the trot in less than a month presaging many more this year as dearth of ...
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- Glaxo knew of heart risk from Avandia, report saysAvandia came on the market in 1999 and achieved annual revenue of $3 billion by 2006, including sales of a combination drug that includes A...
- DoT okays global carriers’ remote access demandThe department of telecom has agreed to a demand by foreign carriers in India - AT&T, British Telecom, France Telecom, Verizon & Cable & Wi...
- AT&T, BT, Verizon form association for liaison with Govt, TRAIFive global telecom service providers providing non-voice long-distance enterprise services like AT&T, BT and Verizon on Monday announced f...
- Manila transport groups to meet on oil pricesManila's public transport operators will meet Monday to consider industrial action after petrol and diesel prices were increased for the 15...
Load More
